Search all trials

Find therapies in clinical trials near you – page 3

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Breast cancer+2

Recruiting

Registered drugNo placebo

A Study Comparing RLY-2608 and Fulvestrant with Capivasertib and Fulvestrant for Patients with PIK3CA-Mutant Hormone Receptor Positive, HER2-Negative Advanced Breast Cancer

Registered drugNo placebo

Hungary

Participants:18–64 years · 65+ years
Substances:Capivasertib

Contact Research Centre

Endometrial cancer+1

Recruiting

Registered drugNo placebo

A study comparing BNT323 with chemotherapy in patients with HER2-expressing recurrent endometrial cancer who received previous treatment

Registered drugNo placebo

Hungary

Participants:18–64 years · 65+ years
Substances:Db-1303

Contact Research Centre

Small cell lung cancer recurrent

Recruiting

Registered drugNo placebo

Study comparing GSK5764227 and topotecan in adults with relapsed small cell lung cancer

Registered drugNo placebo

Hungary

Participants:18–64 years · 65+ years
Substances:GSK5764227

Contact Research Centre

Triple negative breast cancer

Recruiting

Registered drugNo placebo

Study of sacituzumab tirumotecan, pembrolizumab and chemotherapy combination for early-stage triple-negative breast cancer or hormone receptor-low positive/HER2-negative breast cancer

Registered drugNo placebo

Hungary

Participants:18–64 years · 65+ years
Substances:Capecitabine

Contact Research Centre

Non-small cell lung cancer+2

Recruiting

Registered drugNo placebo

Study of THIO and cemiplimab compared to chemotherapy in patients with advanced non-small cell lung cancer who have received two previous treatments

Registered drugNo placebo

Hungary

Participants:18–64 years · 65+ years
Substances:Cemiplimab

Contact Research Centre

Hormone receptor positive breast cancer+1

Recruiting

Registered drugNo placebo

Study of patritumab deruxtecan versus drug combination in patients with hormone receptor-positive, HER2-negative advanced or metastatic breast cancer

Registered drugNo placebo

Hungary

Participants:18–64 years · 65+ years
Substances:Capecitabine

Contact Research Centre

Non-small cell lung cancer stage IV

Recruiting

Registered drugNo placebo

Study of raludotatug deruxtecan, ifinatamab deruxtecan and docetaxel in patients with previously treated stage IV squamous non-small cell lung cancer

Registered drugNo placebo

Hungary

Participants:18–64 years · 65+ years
Substances:Docetaxel

Contact Research Centre

Non-small cell lung cancer+1

Recruiting

Registered drugNo placebo

Study of ifinatamab deruxtecan, raludotatug deruxtecan and docetaxel in previously treated stage IV non-small cell lung cancer patients

Registered drugNo placebo

Hungary

Participants:18–64 years · 65+ years
Substances:Docetaxel

Contact Research Centre

Non-small cell lung cancer

Recruiting

Registered drugNo placebo

Study comparing NVL-655 to alectinib in untreated patients with ALK-positive advanced non-small cell lung cancer

Registered drugNo placebo

Hungary

Participants:18–64 years · 65+ years
Substances:Nvl-655

Contact Research Centre

Small cell lung cancer extensive stage

Recruiting

Registered drugNo placebo

Study Comparing Sacituzumab Govitecan and Standard Treatment for Patients with Previously Treated Extensive Stage Small Cell Lung Cancer

Registered drugNo placebo

Hungary

Participants:18–64 years · 65+ years
Substances:Topotecan

Contact Research Centre

Psoriatic arthropathy

Recruiting

Investigational

Study on the Effectiveness and Safety of JNJ-77242113 for Patients with Active Psoriatic Arthritis Who Have Previously Used Biologic Treatments

Investigational

Hungary

Participants:18–64 years · 65+ years
Substances:Jnj-77242113

Contact Research Centre

Ovarian cancer recurrent+1

Recruiting

Registered drugNo placebo

Study of Sacituzumab Tirumotecan and Bevacizumab for Patients with Recurrent Ovarian Cancer

Registered drugNo placebo

Hungary

Participants:18–64 years · 65+ years
Substances:Bevacizumab

Contact Research Centre

Find therapies in clinical trials near you – page 3

138 trials match your criteria

Breast cancer+2

A Study Comparing RLY-2608 and Fulvestrant with Capivasertib and Fulvestrant for Patients with PIK3CA-Mutant Hormone Receptor Positive, HER2-Negative Advanced Breast Cancer

Endometrial cancer+1

A study comparing BNT323 with chemotherapy in patients with HER2-expressing recurrent endometrial cancer who received previous treatment

Small cell lung cancer recurrent

Study comparing GSK5764227 and topotecan in adults with relapsed small cell lung cancer

Triple negative breast cancer

Study of sacituzumab tirumotecan, pembrolizumab and chemotherapy combination for early-stage triple-negative breast cancer or hormone receptor-low positive/HER2-negative breast cancer

Non-small cell lung cancer+2

Study of THIO and cemiplimab compared to chemotherapy in patients with advanced non-small cell lung cancer who have received two previous treatments

Hormone receptor positive breast cancer+1

Study of patritumab deruxtecan versus drug combination in patients with hormone receptor-positive, HER2-negative advanced or metastatic breast cancer

Non-small cell lung cancer stage IV

Study of raludotatug deruxtecan, ifinatamab deruxtecan and docetaxel in patients with previously treated stage IV squamous non-small cell lung cancer

Non-small cell lung cancer+1

Study of ifinatamab deruxtecan, raludotatug deruxtecan and docetaxel in previously treated stage IV non-small cell lung cancer patients

Non-small cell lung cancer

Study comparing NVL-655 to alectinib in untreated patients with ALK-positive advanced non-small cell lung cancer

Small cell lung cancer extensive stage

Study Comparing Sacituzumab Govitecan and Standard Treatment for Patients with Previously Treated Extensive Stage Small Cell Lung Cancer

Psoriatic arthropathy

Study on the Effectiveness and Safety of JNJ-77242113 for Patients with Active Psoriatic Arthritis Who Have Previously Used Biologic Treatments

Ovarian cancer recurrent+1

Study of Sacituzumab Tirumotecan and Bevacizumab for Patients with Recurrent Ovarian Cancer

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.